Lead Product(s): Eptinezumab
Therapeutic Area: Neurology
Highest Development Status: Approved Product Type: Large molecule
Partner/Sponsor/Collaborator: Orsini Pharmaceutical
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Agreement April 22, 2020
Orsini Pharmaceutical has been selected as one of a very limited number of distribution partners for VYEPTI™ (eptinezumab-jjmr).